Autoimmune haemolytic anaemia: recent advances in pathogenesis, diagnosis and treatment.
The diagnosis and management of patients with autoimmune haemolytic anaemia demands knowledge of various aspects of both clinical and laboratory medicine. There is an apparent gap of communication between the serologist and the clinical physician due to the high specialization of both. The purpose of this annotation is to close some of these gaps by relating the serological data to the diagnosis, severity of disease, treatment, and prognosis.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000744:Anemia, Hemolytic, Autoimmune / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D003298:Coombs Test; D004912:Erythrocytes / Q000276:immunology; D006801:Humans; D007104:Immune Adherence Reaction; D011379:Prognosis; D011951:Receptors, Complement / Q000276:immunology; D011961:Receptors, Fc / Q000276:immunology; D013156:Splenectomy
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D011951:Receptors, Complement; D011961:Receptors, Fc